Abstract
Many biomarker discovery studies are based on matrix‐assisted laser desorption/ionisation (MALDI) peptide profiles. In this study, 96 human serum samples were analysed on a Bruker solariX TM MALDI Fourier transform ion cyclotron resonance (FTICR) system equipped with a 15 tesla magnet. Isotopically resolved peptides were observed in ultrahigh resolution FTICR profiles up to m/z 6500 with mass measurement errors (MMEs) of previously identified peptides at a sub‐ppm level. For comparison with our previous platform for peptide profile mass analysis ( i.e. Ultraflex II) the corresponding time‐of‐flight (TOF) spectra were obtained with isotopically resolved peptides up to m/z 3500. The FTICR and TOF systems performed rather similar with respect to the repeatability of the signal intensities. However, the mass measurement precision improved at least 10‐fold in ultrahigh resolution data and thus simplified spectral alignment necessary for robust and quantitatively precise comparisons of profiles in large‐scale clinical studies. From each single MALDI‐FTICR spectrum an m/z ‐list was obtained with sub‐ppm precision for all different species, which is beneficial for identification purposes and interlaboratory comparisons. Furthermore, the FTICR system allowed new peptide identifications from collision‐induced dissociation (CID) spectra using direct infusion of reversed‐phase (RP) C 18 ‐fractionated serum samples on an electrospray ionisation (ESI) source. Copyright © 2011 John Wiley & Sons, Ltd.

This publication has 27 references indexed in Scilit: